Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should recommendations for colorectal-cancer screening be changed?

Nature Clinical Practice Oncology volume 4, pages 392–393 (2007)Cite this article

boxed-textRegula J et al. (2006) Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355: 1863–1872

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chlebowski RT et al. (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350: 991–1004

    Article  CAS  Google Scholar 

  2. Imperiale TF et al. (2003) Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 139: 959–965

    Article  Google Scholar 

  3. Macafee DA and Scholefield JH (2003) Population based endoscopic screening for colorectal cancer. Gut 52: 323–326

    Article  CAS  Google Scholar 

  4. Allison JE (2005) Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT Editorial Gastroenterology 129: 745–748

    Article  Google Scholar 

  5. American Cancer Society (2007) Cancer facts and figures 2007. [http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf] (accessed 20 April 2007)

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Gastroenterology, San Francisco General Hospital, 1001 Potrero Avenue NH–3D, San Francisco, CA 94110, USA jallison@medsfgh.ucsf.edu

Authors and Affiliations

  1. JE Allison is a Faculty Member in the Gastroenterology Division, and Clinical Professor of Medicine Emeritus, of the University of California San Francisco, San Francisco, CA, USA.,

    James E Allison

Authors
  1. James E Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

JE Allison serves as a consultant to Quest Diagnostics and Beckman Coulter Diagnostics. To date Dr Allison has received no compensation from either company. Both companies manufacture fecal immunochemical tests for colorectal-cancer screening.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allison, J. Should recommendations for colorectal-cancer screening be changed?. Nat Rev Clin Oncol 4, 392–393 (2007). https://doi.org/10.1038/ncponc0843

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0843

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing